Optum, VC Firms Invest $33 Million In Artificial Intelligence Company

Optum Ventures and venture capital firm 8VC recently invested $33 million into artificial intelligence (AI) company IDx. Also involved in the financing were Alpha Edison and Heritage Provider Network.

IDx states that the funds will go toward accelerating adoption of its IDx-DR solution to serve the 30 million Americans living with diabetes. IDx-DR is the first and only U.S. Food and Drugs Administration (FDA) authorized AI system for the autonomous detection of diabetic retinopathy. Diabetic retinopathy is a diabetes complication that affects the eyes, and is caused by damage to the blood vessels in the tissue at . . .